Daniel Kraciun

Dan leads marketing efforts and co-leads product design for Trust.med. His primary focuses are global market integration, communications, and tactical business operations. He brings a decades worth of experience in technical product design, research, and marketing. He is a graduate of Cleveland State University and is certified in GS1 standards for DSCSA suppliers.

About DSCSA Links

What are DSCSA Links? Trust.med’s Registry provides authorized trading partner contact information and drug product information. This information is discoverable by National Drug Code (NDC) or Global Trade Item Number (GTIN). Specific DSCSA contact information can be set by the authoritative source of the NDC or GTIN for regulatory collaboration.  DSCSA links are endpoints (e.g. … Read more

Global Trade Item Number (GTIN)

What is a Global Trade Item Number (GTIN)?A Global Trade Item Number (GTIN) is a unique and internationally recognized identifier for a product. The Global Trade Item Number (GTIN) provides a global standard for identifying trade items in the supply chain. GTIN’s are embedded within the 2D Data matrix printed on certain human drug product … Read more

National Drug Code (NDC)

What is a National Drug Code (NDC)?The NDC, or National Drug Code, is a unique 10-digit or 11-digit, 3-segment number, and a universal product identifier for human drugs in the United States. The 3 segments of the NDC identify: the labeler, the product, and the commercial package size. Searching by NDCTrust.med’s Registry is searchable by … Read more

How to Search Trust.med’s Registry

About Registry Search Trust.med provides a contact and product information registry for pharmaceutical trading partners. Trust.med’s Registry is searchable by product identifiers. Search the Registry with: Search Results Searching the Trust.med Registry will provide product and contact information of the trading partner in control of the NDC, GTIN, or GLN.  Accessing Registry Programmatically To learn … Read more

DSCSA for Pharmacies: 3 Must Knows

DSCSA for Pharmacies: 3 Must Knows Data Exchange | Partner Verification | Tracing Requests January 17th, 2023 This is the year the pharmaceutical supply chain must comply with the FDA’s Drug Supply Chain Security Act (DSCSA). These requirements must be met in order to operate within the US Drug Supply Chain. As the primary touchpoint … Read more

The Drug Manufacturer’s DSCSA Dilemma

A decade’s worth of time has expired since the Drug Supply Chain Security Act (DSCSA) was passed to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. This November marks the start of the 12 month countdown requiring pharmaceutical trading partners to comply with the law. As time quickly slips away, trading partners are still left with unanswered questions and serious operational risks if found to be non-compliant by November 27, 2023.